Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Neurocognitive effects of ketamine in treatment-resistant major depression: association with antidepressant response.

Murrough JW, Wan LB, Iacoviello B, Collins KA, Solon C, Glicksberg B, Perez AM, Mathew SJ, Charney DS, Iosifescu DV, Burdick KE.

Psychopharmacology (Berl). 2013 Sep 11. [Epub ahead of print]

PMID:
24022236
[PubMed - as supplied by publisher]
2.

Neurocognitive Effects of Ketamine and Association with Antidepressant Response in Individuals with Treatment-Resistant Depression: A Randomized Controlled Trial.

Murrough JW, Burdick KE, Levitch CF, Perez AM, Brallier JW, Chang LC, Foulkes A, Charney DS, Mathew SJ, Iosifescu DV.

Neuropsychopharmacology. 2014 Nov 6. doi: 10.1038/npp.2014.298. [Epub ahead of print]

PMID:
25374095
[PubMed - as supplied by publisher]
3.

Neurocognitive performance and serial intravenous subanesthetic ketamine in treatment-resistant depression.

Shiroma PR, Albott CS, Johns B, Thuras P, Wels J, Lim KO.

Int J Neuropsychopharmacol. 2014 Nov;17(11):1805-13. doi: 10.1017/S1461145714001011. Epub 2014 Jun 25.

PMID:
24963561
[PubMed - in process]
4.

Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial.

Mathew SJ, Murrough JW, aan het Rot M, Collins KA, Reich DL, Charney DS.

Int J Neuropsychopharmacol. 2010 Feb;13(1):71-82. doi: 10.1017/S1461145709000169. Epub 2009 Mar 17.

PMID:
19288975
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

The role of ketamine in treatment-resistant depression: a systematic review.

Serafini G, Howland RH, Rovedi F, Girardi P, Amore M.

Curr Neuropharmacol. 2014 Sep;12(5):444-61. doi: 10.2174/1570159X12666140619204251.

PMID:
25426012
[PubMed]
Free PMC Article
6.

Neurocognitive profiles in treatment-resistant bipolar I and bipolar II disorder depression.

Kessler U, Schoeyen HK, Andreassen OA, Eide GE, Hammar Å, Malt UF, Oedegaard KJ, Morken G, Sundet K, Vaaler AE.

BMC Psychiatry. 2013 Apr 4;13:105. doi: 10.1186/1471-244X-13-105.

PMID:
23557429
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression.

Murrough JW, Perez AM, Pillemer S, Stern J, Parides MK, aan het Rot M, Collins KA, Mathew SJ, Charney DS, Iosifescu DV.

Biol Psychiatry. 2013 Aug 15;74(4):250-6. doi: 10.1016/j.biopsych.2012.06.022. Epub 2012 Jul 27.

PMID:
22840761
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

An empirical evaluation of the MATRICS Consensus Cognitive Battery in bipolar disorder.

Van Rheenen TE, Rossell SL.

Bipolar Disord. 2014 May;16(3):318-25. doi: 10.1111/bdi.12134. Epub 2013 Oct 9.

PMID:
24119238
[PubMed - indexed for MEDLINE]
9.

Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial.

Murrough JW, Iosifescu DV, Chang LC, Al Jurdi RK, Green CE, Perez AM, Iqbal S, Pillemer S, Foulkes A, Shah A, Charney DS, Mathew SJ.

Am J Psychiatry. 2013 Oct;170(10):1134-42. doi: 10.1176/appi.ajp.2013.13030392.

PMID:
23982301
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.

Zarate CA Jr, Singh JB, Carlson PJ, Brutsche NE, Ameli R, Luckenbaugh DA, Charney DS, Manji HK.

Arch Gen Psychiatry. 2006 Aug;63(8):856-64.

PMID:
16894061
[PubMed - indexed for MEDLINE]
11.

Rapid Antidepressant Response with Ketamine: Is it the Solution to Resistant Depression?

Thakurta RG, Ray P, Kanji D, Das R, Bisui B, Singh OP.

Indian J Psychol Med. 2012 Jan;34(1):56-60. doi: 10.4103/0253-7176.96161.

PMID:
22661809
[PubMed]
Free PMC Article
12.

A review of ketamine in affective disorders: current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action.

Naughton M, Clarke G, O'Leary OF, Cryan JF, Dinan TG.

J Affect Disord. 2014 Mar;156:24-35. doi: 10.1016/j.jad.2013.11.014. Epub 2013 Dec 10. Review.

PMID:
24388038
[PubMed - indexed for MEDLINE]
13.

D-serine plasma concentration is a potential biomarker of (R,S)-ketamine antidepressant response in subjects with treatment-resistant depression.

Moaddel R, Luckenbaugh DA, Xie Y, Villaseñor A, Brutsche NE, Machado-Vieira R, Ramamoorthy A, Lorenzo MP, Garcia A, Bernier M, Torjman MC, Barbas C, Zarate CA Jr, Wainer IW.

Psychopharmacology (Berl). 2015 Jan;232(2):399-409. doi: 10.1007/s00213-014-3669-0. Epub 2014 Jul 24.

PMID:
25056852
[PubMed - in process]
14.

Sex differences in the rapid and the sustained antidepressant-like effects of ketamine in stress-naïve and "depressed" mice exposed to chronic mild stress.

Franceschelli A, Sens J, Herchick S, Thelen C, Pitychoutis PM.

Neuroscience. 2015 Jan 14;290C:49-60. doi: 10.1016/j.neuroscience.2015.01.008. [Epub ahead of print]

PMID:
25595985
[PubMed - as supplied by publisher]
15.

Effect of baseline anxious depression on initial and sustained antidepressant response to ketamine.

Ionescu DF, Luckenbaugh DA, Niciu MJ, Richards EM, Slonena EE, Vande Voort JL, Brutsche NE, Zarate CA Jr.

J Clin Psychiatry. 2014 Sep;75(9):e932-8. doi: 10.4088/JCP.14m09049.

PMID:
25295436
[PubMed - indexed for MEDLINE]
16.

A randomized controlled trial of intranasal ketamine in major depressive disorder.

Lapidus KA, Levitch CF, Perez AM, Brallier JW, Parides MK, Soleimani L, Feder A, Iosifescu DV, Charney DS, Murrough JW.

Biol Psychiatry. 2014 Dec 15;76(12):970-6. doi: 10.1016/j.biopsych.2014.03.026. Epub 2014 Apr 3.

PMID:
24821196
[PubMed - in process]
17.

Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder.

Murrough JW, Collins KA, Fields J, DeWilde KE, Phillips ML, Mathew SJ, Wong E, Tang CY, Charney DS, Iosifescu DV.

Transl Psychiatry. 2015 Feb 17;5:e509. doi: 10.1038/tp.2015.10.

PMID:
25689570
[PubMed - in process]
18.

Synaptic potentiation is critical for rapid antidepressant response to ketamine in treatment-resistant major depression.

Cornwell BR, Salvadore G, Furey M, Marquardt CA, Brutsche NE, Grillon C, Zarate CA Jr.

Biol Psychiatry. 2012 Oct 1;72(7):555-61. doi: 10.1016/j.biopsych.2012.03.029. Epub 2012 Apr 21.

PMID:
22521148
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Family history of alcohol dependence and antidepressant response to an N-methyl-D-aspartate antagonist in bipolar depression.

Luckenbaugh DA, Ibrahim L, Brutsche N, Franco-Chaves J, Mathews D, Marquardt CA, Cassarly C, Zarate CA Jr.

Bipolar Disord. 2012 Dec;14(8):880-7. doi: 10.1111/bdi.12003. Epub 2012 Sep 14.

PMID:
22978511
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

Rapid response with ketamine on suicidal cognition in resistant depression.

Thakurta RG, Das R, Bhattacharya AK, Saha D, Sen S, Singh OP, Bisui B.

Indian J Psychol Med. 2012 Apr;34(2):170-5. doi: 10.4103/0253-7176.101793.

PMID:
23162195
[PubMed]
Free PMC Article
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk